| - GRCh37:
- ChrX:123019513-123041031
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022556
- GRCh38:
- ChrX:123888706
| XIAP | K322R | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034500
- GRCh38:
- ChrX:123900650
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025082
- GRCh38:
- ChrX:123891232
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019983
- GRCh38:
- ChrX:123886133
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020155
- GRCh38:
- ChrX:123886305
| XIAP | R215C | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019773
- GRCh38:
- ChrX:123885923
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040895
- GRCh38:
- ChrX:123907045
| XIAP | C453Y | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019646
- GRCh38:
- ChrX:123885796
| XIAP | S45L | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040965
- GRCh38:
- ChrX:123907115
| XIAP | E476D | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019657
- GRCh38:
- ChrX:123885807
| XIAP | R49* | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123026623
- GRCh38:
- ChrX:123892773
| XIAP | D367N | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019920
- GRCh38:
- ChrX:123886070
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020319
- GRCh38:
- ChrX:123886469
| XIAP | I269M | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Jan 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020178
- GRCh38:
- ChrX:123886328
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034542
- GRCh38:
- ChrX:123900692
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034365
- GRCh38:
- ChrX:123900515
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025176-123025177
- GRCh38:
- ChrX:123891326-123891327
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025119
- GRCh38:
- ChrX:123891269
| XIAP | E337* | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034507
- GRCh38:
- ChrX:123900657
| XIAP | M422V | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034329
- GRCh38:
- ChrX:123900479
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019530
- GRCh38:
- ChrX:123885680
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025152
- GRCh38:
- ChrX:123891302
| XIAP | L348F | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040821
- GRCh38:
- ChrX:123906971
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025099-123025100
- GRCh38:
- ChrX:123891249-123891250
| XIAP | L331fs | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019839
- GRCh38:
- ChrX:123885989
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019950
- GRCh38:
- ChrX:123886100
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025089
- GRCh38:
- ChrX:123891239
| XIAP | C327S | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020250
- GRCh38:
- ChrX:123886400
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025125
- GRCh38:
- ChrX:123891275
| XIAP | I339V | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019680
- GRCh38:
- ChrX:123885830
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019976
- GRCh38:
- ChrX:123886126
| XIAP | P155L | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020256
- GRCh38:
- ChrX:123886406
| XIAP | R248S | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040966
- GRCh38:
- ChrX:123907116
| XIAP | A477T | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019692
- GRCh38:
- ChrX:123885842
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040837
- GRCh38:
- ChrX:123906987
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019977
- GRCh38:
- ChrX:123886127
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019990
- GRCh38:
- ChrX:123886140
| XIAP | M160V | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040918
- GRCh38:
- ChrX:123907068
| XIAP | V461I | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020044
- GRCh38:
- ChrX:123886194
| XIAP | H178Y | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123014249-123021822
- GRCh38:
- ChrX:123880399-123887972
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely pathogenic (Dec 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025176-123025177
- GRCh38:
- ChrX:123891326-123891327
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019795
- GRCh38:
- ChrX:123885945
| XIAP | G95S | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jun 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123026620
- GRCh38:
- ChrX:123892770
| XIAP | I366V | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034550
- GRCh38:
- ChrX:123900700
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034329
- GRCh38:
- ChrX:123900479
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034485
- GRCh38:
- ChrX:123900635
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034473
- GRCh38:
- ChrX:123900623
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019958
- GRCh38:
- ChrX:123886108
| XIAP | I149T | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019808
- GRCh38:
- ChrX:123885958
| XIAP | E99G | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019584
- GRCh38:
- ChrX:123885734
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022506
- GRCh38:
- ChrX:123888656
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025185
- GRCh38:
- ChrX:123891335
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034324
- GRCh38:
- ChrX:123900474
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020396-123020397
- GRCh38:
- ChrX:123886546-123886547
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040851
- GRCh38:
- ChrX:123907001
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040974
- GRCh38:
- ChrX:123907124
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019998
- GRCh38:
- ChrX:123886148
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Sep 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123026643
- GRCh38:
- ChrX:123892793
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Feb 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040818
- GRCh38:
- ChrX:123906968
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Apr 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025184-123025185
- GRCh38:
- ChrX:123891334-123891335
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034560
- GRCh38:
- ChrX:123900710
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jun 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020061
- GRCh38:
- ChrX:123886211
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Oct 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020314
- GRCh38:
- ChrX:123886464
| XIAP | R268W | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034477
- GRCh38:
- ChrX:123900627
| XIAP | A412S | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040854-123040855
- GRCh38:
- ChrX:123907004-123907005
| XIAP | Q440* | X-linked lymphoproliferative disease due to XIAP deficiency | Likely pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040919
- GRCh38:
- ChrX:123907069
| XIAP | F462fs | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020120-123020122
- GRCh38:
- ChrX:123886270-123886272
| XIAP | G205del | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020290
- GRCh38:
- ChrX:123886440
| XIAP | P260S | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123025158
- GRCh38:
- ChrX:123891308
| XIAP | E350* | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Jun 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:122318388-123505241
| STAG2, THOC2, XIAP, GRIA3, SH2D1A | | not provided, X-linked lymphoproliferative disease due to XIAP deficiency | Conflicting interpretations of pathogenicity (Dec 23, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:123022510-123022513
- GRCh38:
- ChrX:123888660-123888663
| XIAP | T308fs | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022478
- GRCh38:
- ChrX:123888628
| XIAP | D296G | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040852
- GRCh38:
- ChrX:123907002
| XIAP | E439* | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019880
- GRCh38:
- ChrX:123886030
| XIAP | S123N | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019513-123020409
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020317
- GRCh38:
- ChrX:123886467
| XIAP | I269L | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020264-123020265
- GRCh38:
- ChrX:123886414-123886415
| XIAP | N252fs | X-linked lymphoproliferative disease due to XIAP deficiency | Pathogenic (Sep 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020021
- GRCh38:
- ChrX:123886171
| XIAP | F170Y | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019971
- GRCh38:
- ChrX:123886121
| XIAP | I153M | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020209
- GRCh38:
- ChrX:123886359
| XIAP | R233W | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040865
- GRCh38:
- ChrX:123907015
| XIAP | R443H | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019812
- GRCh38:
- ChrX:123885962
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019693
- GRCh38:
- ChrX:123885843
| XIAP | V61M | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020228
- GRCh38:
- ChrX:123886378
| XIAP | S239N | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Nov 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019715
- GRCh38:
- ChrX:123885865
| XIAP | A68V | not provided, X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:123020093
- GRCh38:
- ChrX:123886243
| XIAP | I194N | X-linked lymphoproliferative disease due to XIAP deficiency | Uncertain significance (Jun 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022464
- GRCh38:
- ChrX:123888614
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123040953
- GRCh38:
- ChrX:123907103
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034439
- GRCh38:
- ChrX:123900589
| XIAP | I399R | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034437
- GRCh38:
- ChrX:123900587
| XIAP | Q398H | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019535
- GRCh38:
- ChrX:123885685
| XIAP | G8E | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123026599
- GRCh38:
- ChrX:123892749
| XIAP | T359A | X-linked lymphoproliferative disease due to XIAP deficiency | Conflicting interpretations of pathogenicity (Feb 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:123019820
- GRCh38:
- ChrX:123885970
| XIAP | T103M | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123019658
- GRCh38:
- ChrX:123885808
| XIAP | R49Q | X-linked lymphoproliferative disease due to XIAP deficiency | Benign (Apr 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022479-123022483
- GRCh38:
- ChrX:123888629-123888633
| XIAP | K299fs | X-linked lymphoproliferative disease due to XIAP deficiency, not provided | Pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:123034344
- GRCh38:
- ChrX:123900494
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Aug 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123020382
- GRCh38:
- ChrX:123886532
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Aug 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123034392
- GRCh38:
- ChrX:123900542
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (May 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:123022465
- GRCh38:
- ChrX:123888615
| XIAP | | X-linked lymphoproliferative disease due to XIAP deficiency | Likely benign (Jul 25, 2022) | criteria provided, single submitter |